Muscle injuries, occurring recreationally as well as in the workplace and home, are among the most common musculoskeletal conditions in the U.S. Satellite cells provide muscle with the potential for regeneration, but for large defects, slow healing and excessive proliferation of fibroblasts frequently results in fibrosis and scarring that can create a mechanical barrier that delays or restricts myofibers from bridging the injury gap. Recent findings have begun to elucidate differences between inflammatory processes that promote muscle repair and regeneration following injury and those that disrupt muscle homeostasis. In light of the multiple demands needed for preventing fibrotic scarring, a multidisciplinary team has been assembled to apply a proactive strategy in which multiple biomolecules are delivered in a site-specific and temporally orchestrated manner to treat different aspects of the inflammatory and wound healing processes.
Aim 1 will develop and characterize a mechanically flexible controlled release system for localized delivery of anti- inflammatory, anti-oxidant, pro-resolution, and anti-fibrotic biomolecules. With respect to this Aim, it is hypothesized that the devices can be tailored to deliver anti-inflammatory, anti-oxidant pro-resolution, and anti-fibrotic molecules with discrete profiles that roughly follow the kineticsof the wound healing process.
Aim 2 will determine the efficacy of controlled, localized, sequential release of anti-inflammatory, anti- oxidant, pro-resolution, and anti-fibrotic components to enhance structural/histological, biochemical, and functional properties in vivo in a rodent skeletal muscle defect model. The working hypothesis is that sequential treatment devices, i.e., materials that resolve inflammation and then prevent fibrosis, will not only enhance muscle regeneration, but these films will be more effective than those releasing only one of the components or that deliver them without regard to the sequence of events during wound healing. Furthermore, the methods may be applicable not only to repair of skeletal muscle defects but also for treatment of many other diseases in which control of inflammation and subsequent wound healing processes is needed.

Public Health Relevance

Muscle injuries, occurring recreationally as well as in the workplace and home, are among the most common musculoskeletal conditions in the U.S. Although muscle has the potential to regenerate, slow healing of large defects frequently results in scarring and incomplete recovery. This project will develop bioerodible films that control different phases of wound healing to enhance muscle regeneration.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR060964-01A1
Application #
8372021
Study Section
Musculoskeletal Tissue Engineering Study Section (MTE)
Program Officer
Boyce, Amanda T
Project Start
2012-08-01
Project End
2016-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
1
Fiscal Year
2012
Total Cost
$313,435
Indirect Cost
$88,435
Name
University of Kentucky
Department
Biomedical Engineering
Type
Other Domestic Higher Education
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Jennings, Cheryl L; Perry, Ellis K; Dziubla, Thomas D et al. (2017) Sequential Release of Multiple Drugs from Flexible Drug Delivery Films. Int J Polym Mater 66:569-576
Asafo-Adjei, Theodora A; Dziubla, Thomas D; Puleo, David A (2017) Tuning Properties of Poly(ethylene glycol)-block-poly(simvastatin) Copolymers Synthesized via Triazabicyclodecene. React Funct Polym 119:37-46
Asafo-Adjei, T A; Chen, A J; Najarzadeh, A et al. (2016) Advances in Controlled Drug Delivery for Treatment of Osteoporosis. Curr Osteoporos Rep 14:226-38
Sundararaj, Sharath C; Al-Sabbagh, Mohanad; Rabek, Cheryl L et al. (2016) Comparison of sequential drug release in vitro and in vivo. J Biomed Mater Res B Appl Biomater 104:1302-10
Jennings, Cheryl L; Dziubla, Thomas D; Puleo, David A (2016) Combined Effects of Drugs and Plasticizers on the Properties of Drug Delivery Films. J Bioact Compat Polym 31:323-333
Clark, Amanda; Milbrandt, Todd A; Hilt, J Zach et al. (2014) Retention of insulin-like growth factor I bioactivity during the fabrication of sintered polymeric scaffolds. Biomed Mater 9:025015
Sundararaj, Sharath C; Thomas, Mark V; Dziubla, Thomas D et al. (2014) Bioerodible system for sequential release of multiple drugs. Acta Biomater 10:115-25
Rabek, Cheryl L; Van Stelle, Rachel; Dziubla, Thomas D et al. (2014) The effect of plasticizers on the erosion and mechanical properties of polymeric films. J Biomater Appl 28:779-89
Asafo-Adjei, Theodora A; Dziubla, Thomas D; Puleo, David A (2014) Synthesis and Characterization of a Poly(ethylene glycol)-Poly(simvastatin) Diblock Copolymer. RSC Adv 4:58287-58298
Fisher, Paul D; Palomino, Pablo; Milbrandt, Todd A et al. (2014) Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(?-amino ester) and hydroxyapatite microparticles. J Biomater Sci Polym Ed 25:1174-93

Showing the most recent 10 out of 12 publications